Back to rounds

Company profile

QL Biopharma

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Location
Changping, Beijing, China, Asia
Website
qlbiopharm.com

Latest known funding

Series C round

Capital
$44.7M
Announced
Sep 14, 2026